At the age of 37 years, exome sequencing (ES) revealed a homozygous mutation c.1929‐2A>G in MAN2B1, affecting the splice acceptor site at Exon 16 and confirming the diagnosis of AM. This evidence concerns the gene MAN2B1 and acute myeloblastic leukemia with maturation.